About Avana Super 100/
Avana Super 100/60 mg Sunrise is a dual-mechanism research compound combining avanafil (100 mg) and dapoxetine (60 mg) formulated for laboratory investigation. Avanafil functions as a phosphodiesterase-5 inhibitor, while dapoxetine operates as a selective serotonin reuptake inhibitor, providing researchers with a unique dual-pathway compound for comprehensive studies. This combination enables examination of both vascular and neurochemical pathways in controlled laboratory environments, making it valuable for researchers investigating the interaction between these distinct molecular mechanisms.
Laboratory Applications
Research teams study this compound to examine phosphodiesterase-5 inhibition effects alongside selective serotonin reuptake mechanisms. The dual formulation allows for investigation of synergistic pathway interactions in experimental models. Avanafil demonstrates rapid onset characteristics in laboratory studies, while dapoxetine provides sustained serotonin transporter modulation for extended research protocols. Scientists at Stroid UK Shop utilise this compound alongside other research materials from our avanafil and dapoxetine collection, complemented by selective androgen receptor modulators from our SARMs research catalogue and experimental peptide compounds for comprehensive molecular investigations.
Technical Specifications
| Parameter | Specification |
|---|---|
| Active Compounds | Avanafil 100 mg + Dapoxetine 60 mg |
| Manufacturer | Sunrise Remedies |
| Form | Oral tablet |
| Purity | Pharmaceutical grade |
| Storage | Room temperature, dry environment |
| Research Use | In-vitro laboratory studies only |
Laboratory Compliance
This product is manufactured exclusively for in-vitro research purposes and is not intended for human consumption, therapeutic use, or any form of clinical application. Researchers must handle this compound in accordance with laboratory safety protocols and ensure proper storage conditions are maintained. All experimental work should be conducted within appropriate research facilities with suitable containment measures.
